|4Aug 5, 7:52 PM ET

RxSight I, LLC 4

4 · RxSight, Inc. · Filed Aug 5, 2021

Insider Transaction Report

Form 4
Period: 2021-08-03
Transactions
  • Conversion

    Common Stock

    2021-08-03+2,016,7782,016,778 total
  • Conversion

    Series H Preferred Stock

    2021-08-032,016,7780 total
    Common Stock (2,016,778 underlying)
Footnotes (1)
  • [F1]All shares of the Series H Preferred Stock, par value $0.001 per share, of the Issuer automatically converted on a one-for-one basis to shares of the Issuer's common stock, par value $0.001 per share ("Common Stock") immediately prior to the closing of the Issuer's initial public offering of its Common Stock.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION